MyFinsight
Home
Blog
About
Contact
Net income
$45,328K
Accounts receivable
-$22,567K
Proceeds on the sales of
assets held for sale
$5,000K
something is missing
$9,848K
Stock-based compensation
$6,329K
Accrued expenses
$5,105K
Depreciation and
amortization
$1,839K
Deposits and other assets
-$379K
Amortization of debt discount
$191K
Loss on disposal of
fixed assets
-$42K
Net cash provided by
(used in) operating...
$58,249K
Net cash provided by
(used in) investing...
$2,404K
Canceled cashflow
$33,379K
Canceled cashflow
$2,596K
Net increase
(decrease) in cash and cash...
$50,523K
Canceled cashflow
$10,130K
Inventories
$15,633K
Gain on sale of plasma
centers
$7,980K
Deferred income tax
provision
-$6,556K
Prepaid expenses and
other current assets
$1,601K
Accounts payable
-$1,233K
Other current and
non-current liabilities
-$340K
Amortization of license
revenue
-$36K
Jpm revolving
facility proceeds
$125,000K
Net proceeds from
the exercise of...
$588K
Purchase of property and
equipment
$2,543K
Acquisition of intangible
assets
$53K
Net cash used in
financing activities
-$10,130K
Canceled cashflow
$125,588K
Acquisition of treasury
stock
$130,191K
Taxes paid on vested
restricted stock units
$5,058K
Jpm term loan
payments
$469K
Back
Back
Cash Flow
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)
source: myfinsight.com